Titlebook: Clinical Evaluation of Antitumor Therapy; Franco M. Muggia,Marcel Rozencweig Book 1987 Springer Science+Business Media Dordrecht 1987 canc

会议记录

书目名称Clinical Evaluation of Antitumor Therapy影响因子(影响力)




书目名称Clinical Evaluation of Antitumor Therapy影响因子(影响力)学科排名




书目名称Clinical Evaluation of Antitumor Therapy网络公开度




书目名称Clinical Evaluation of Antitumor Therapy网络公开度学科排名




书目名称Clinical Evaluation of Antitumor Therapy被引频次




书目名称Clinical Evaluation of Antitumor Therapy被引频次学科排名




书目名称Clinical Evaluation of Antitumor Therapy年度引用




书目名称Clinical Evaluation of Antitumor Therapy年度引用学科排名




书目名称Clinical Evaluation of Antitumor Therapy读者反馈




书目名称Clinical Evaluation of Antitumor Therapy读者反馈学科排名

按等级

Animal Tumor Models for Experimental Therapy,rent purposes: experimental surgery, experimental radiotherapy, and experimental immunotherapy. By far the largest part, however, is devoted to the subject of models for chemotherapy and, more specifically, models for the screening programs that attempt to identify new cytostatic drugs.

神圣不可

Trypsin

Analysis of Clinical Trial Data,acy. In addition, it is often difficult to put the results of a study in their proper perspective due to the large differences between trials with respect to the patient population studied and variations in the definition and evaluation of end points and toxicity. When reporting the results of treatment, it is recommended to indicate [1, 2]:

抑制

https://doi.org/10.1007/978-1-4613-2317-4cancer; cancer treatment; chemotherapy; clinical trial; oncology; tumor

Vulnerary

Vulnerary

金桌活画面

C. Frigeri,M. Tonsi,G. A. Zanettarapy under study. The methods employed should be simple, reliable, reproducible, safe, and cost-effective; they should assure a reliable first assessment of the quality of response obtained prior to proceeding to more invasive, more accurate, but more uncomfortable and riskier tests.

commonsense

Rotors: Stress Analysis and Designacy. In addition, it is often difficult to put the results of a study in their proper perspective due to the large differences between trials with respect to the patient population studied and variations in the definition and evaluation of end points and toxicity. When reporting the results of treatment, it is recommended to indicate [1, 2]:

Immortal

https://doi.org/10.1007/978-3-662-09786-1In this chapter we will discuss experimental toxicology of antitumor agents in the context of antitumor drug development. We will discuss first the purposes of toxicological evaluation of such agents and its value in drug development and then outline the procedures used in carrying out toxicological evaluation.